lentivirus expressing shrna constructs Search Results


90
Broad Institute Inc plasmid /lentivirus constructs plko-shrnas for gopc
Plasmid /Lentivirus Constructs Plko Shrnas For Gopc, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/plasmid++lentivirus+constructs+plko+shrnas+for+gopc/pmc04414737-45-5-11
Average 90 stars, based on 1 article reviews
plasmid /lentivirus constructs plko-shrnas for gopc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
VectorBuilder GmbH lentivirus expressing control shrna
Lentivirus Expressing Control Shrna, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/lentivirus+expressing+control+shrna/10__1074_slash_jbc__ra119__008360-171-4-13
Average 90 stars, based on 1 article reviews
lentivirus expressing control shrna - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma low expression lentivirus shrna hotair (sh− hotair)
Low Expression Lentivirus Shrna Hotair (Sh− Hotair), supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/low+expression+lentivirus+shrna+hotair++sh++hotair+/pm34391823-68-2-17
Average 90 stars, based on 1 article reviews
low expression lentivirus shrna hotair (sh− hotair) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
VectorBuilder GmbH lentivirus: scrambled- and tβriii-targeted lentiviral shrna expression vectors with predesigned sequences including puromycin-resistant gene
Lentivirus: Scrambled And Tβriii Targeted Lentiviral Shrna Expression Vectors With Predesigned Sequences Including Puromycin Resistant Gene, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/lentivirus++scrambled++and+t%CE%B2riii+targeted+lentiviral+shrna+expression+vectors+with+predesigned+sequences+including+puromycin+resistant+gene/pm39481440-347-17-21
Average 90 stars, based on 1 article reviews
lentivirus: scrambled- and tβriii-targeted lentiviral shrna expression vectors with predesigned sequences including puromycin-resistant gene - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Broad Institute Inc plasmids encoding lentivirus expressing shrna molecules
Plasmids Encoding Lentivirus Expressing Shrna Molecules, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/plasmids+encoding+lentivirus+expressing+shrna+molecules/pm23892722-594-0-14
Average 90 stars, based on 1 article reviews
plasmids encoding lentivirus expressing shrna molecules - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma lamp2a shrna (sh-lamp2a)-expressing lentivirus
Lamp2a Shrna (Sh Lamp2a) Expressing Lentivirus, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/lamp2a+shrna++sh+lamp2a++expressing+lentivirus/pmc05385397-36-3-19
Average 90 stars, based on 1 article reviews
lamp2a shrna (sh-lamp2a)-expressing lentivirus - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma trem2-interfering aav
Trem2 Interfering Aav, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/lentivirus+expressing+shrna+of+trem2/pm40205810-199-8-17
Average 90 stars, based on 1 article reviews
trem2-interfering aav - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma the activator and inhibitor of kmt2d
(A) ESR1 expression in OV stage II–IV was higher than stage I and Fig. 1B low survival probability related to high ESR1 level from TCGA ( P = 0.022) (B) Immunohistochemical staining images (up) and scores (down) of <t>KMT2D,</t> ESR1 and H3K4me in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including tumor samples and adjacent tissues.). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (C) The protein expression of KMT2D, ESR1, PTGS2, STAT3, VEGFR2 in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including 198 tumor samples and 133 adjacent tissues). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (D) The binding of H3K4me and ESR1 was demonstrated using CHIP analysis and the relative expression of ESR1 was calculated via normalized to the Input group. Scale bar: 50 μm. * P < 0.05 vs adjacent tissues, ** P < 0.01 vs adjacent tissues, # P < 0.05 vs tumor (phase I), ## P < 0.01 vs tumor (phase I).
The Activator And Inhibitor Of Kmt2d, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/lentivirus+expressing+scrambled+vector+kmt2d+shrna/pmc08554562-66-22-26
Average 90 stars, based on 1 article reviews
the activator and inhibitor of kmt2d - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Ribobio co lentivirus expressing control shrna or c-myc shrna (ribobio)
(A) ESR1 expression in OV stage II–IV was higher than stage I and Fig. 1B low survival probability related to high ESR1 level from TCGA ( P = 0.022) (B) Immunohistochemical staining images (up) and scores (down) of <t>KMT2D,</t> ESR1 and H3K4me in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including tumor samples and adjacent tissues.). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (C) The protein expression of KMT2D, ESR1, PTGS2, STAT3, VEGFR2 in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including 198 tumor samples and 133 adjacent tissues). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (D) The binding of H3K4me and ESR1 was demonstrated using CHIP analysis and the relative expression of ESR1 was calculated via normalized to the Input group. Scale bar: 50 μm. * P < 0.05 vs adjacent tissues, ** P < 0.01 vs adjacent tissues, # P < 0.05 vs tumor (phase I), ## P < 0.01 vs tumor (phase I).
Lentivirus Expressing Control Shrna Or C Myc Shrna (Ribobio), supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/lentivirus+expressing+control+shrna+or+c+myc+shrna++ribobio+/pmc06933030-94-23-25
Average 90 stars, based on 1 article reviews
lentivirus expressing control shrna or c-myc shrna (ribobio) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
PSICOR Inc lentivirus-based shrna expression system
(A) ESR1 expression in OV stage II–IV was higher than stage I and Fig. 1B low survival probability related to high ESR1 level from TCGA ( P = 0.022) (B) Immunohistochemical staining images (up) and scores (down) of <t>KMT2D,</t> ESR1 and H3K4me in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including tumor samples and adjacent tissues.). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (C) The protein expression of KMT2D, ESR1, PTGS2, STAT3, VEGFR2 in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including 198 tumor samples and 133 adjacent tissues). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (D) The binding of H3K4me and ESR1 was demonstrated using CHIP analysis and the relative expression of ESR1 was calculated via normalized to the Input group. Scale bar: 50 μm. * P < 0.05 vs adjacent tissues, ** P < 0.01 vs adjacent tissues, # P < 0.05 vs tumor (phase I), ## P < 0.01 vs tumor (phase I).
Lentivirus Based Shrna Expression System, supplied by PSICOR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/lentivirus+based+shrna+expression+system/pmc04295387-362-17-21
Average 90 stars, based on 1 article reviews
lentivirus-based shrna expression system - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
America Pharma Source LLC lentivirus constructs encoding shrna targeting sa11 gene 10
RV-induced dynamic Ca 2+ signaling is related to virus dose. ( A) Immunofluorescence images of mock or SA114F-infected MA104-GCaMP5G cells that were inoculated with increasing MOI (0.1, 1, or 10). RV antigen (red) is detected at ~8 hpi with anti-RV polyclonal antisera and nuclei are stained with DAPI (blue). (B , C) Epifluorescence images of MA104-GCaMP5G cells mock or infected with recombinant <t>SA11-mRuby</t> reporter virus with increasing MOIs (0.1, 1, 10). Images were captured at 7 HPI (B) or 10 HPI (C) . (D) Representative single-cell traces of relative GCaMP5G fluorescence (F/F 0 ) from cells mock (black) or RV infected by SA114F with MOIs of 0.1 (purple), 1 (blue), 10 (red). (E) Representative single-cell traces of relative fluorescence (F/F 0 ) of GCaMP5G (green) and mRuby (red) from cells infected by SA11-mRuby MOI 0.1 (purple) or 1 (blue). (F , G) Number of Ca 2+ spikes (F/F 0 > 5%) from mock or RV-infected cells that were infected with SA114F (F) or SA11-mRuby (G) . Data shown as mean ± SD of 60 cells/condition. **p < 0.01.
Lentivirus Constructs Encoding Shrna Targeting Sa11 Gene 10, supplied by America Pharma Source LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/lentivirus+constructs+encoding+shrna+targeting+sa11+gene+10/pmc06658527-81-0-20
Average 90 stars, based on 1 article reviews
lentivirus constructs encoding shrna targeting sa11 gene 10 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma lentiviruses expressing shrnas against zhx2 and shs100a14
RV-induced dynamic Ca 2+ signaling is related to virus dose. ( A) Immunofluorescence images of mock or SA114F-infected MA104-GCaMP5G cells that were inoculated with increasing MOI (0.1, 1, or 10). RV antigen (red) is detected at ~8 hpi with anti-RV polyclonal antisera and nuclei are stained with DAPI (blue). (B , C) Epifluorescence images of MA104-GCaMP5G cells mock or infected with recombinant <t>SA11-mRuby</t> reporter virus with increasing MOIs (0.1, 1, 10). Images were captured at 7 HPI (B) or 10 HPI (C) . (D) Representative single-cell traces of relative GCaMP5G fluorescence (F/F 0 ) from cells mock (black) or RV infected by SA114F with MOIs of 0.1 (purple), 1 (blue), 10 (red). (E) Representative single-cell traces of relative fluorescence (F/F 0 ) of GCaMP5G (green) and mRuby (red) from cells infected by SA11-mRuby MOI 0.1 (purple) or 1 (blue). (F , G) Number of Ca 2+ spikes (F/F 0 > 5%) from mock or RV-infected cells that were infected with SA114F (F) or SA11-mRuby (G) . Data shown as mean ± SD of 60 cells/condition. **p < 0.01.
Lentiviruses Expressing Shrnas Against Zhx2 And Shs100a14, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/lentivirus+expressing+shrna+against+zhx2/pm35151335-90-6-10
Average 90 stars, based on 1 article reviews
lentiviruses expressing shrnas against zhx2 and shs100a14 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


(A) ESR1 expression in OV stage II–IV was higher than stage I and Fig. 1B low survival probability related to high ESR1 level from TCGA ( P = 0.022) (B) Immunohistochemical staining images (up) and scores (down) of KMT2D, ESR1 and H3K4me in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including tumor samples and adjacent tissues.). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (C) The protein expression of KMT2D, ESR1, PTGS2, STAT3, VEGFR2 in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including 198 tumor samples and 133 adjacent tissues). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (D) The binding of H3K4me and ESR1 was demonstrated using CHIP analysis and the relative expression of ESR1 was calculated via normalized to the Input group. Scale bar: 50 μm. * P < 0.05 vs adjacent tissues, ** P < 0.01 vs adjacent tissues, # P < 0.05 vs tumor (phase I), ## P < 0.01 vs tumor (phase I).

Journal: Cell Transplantation

Article Title: Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer

doi: 10.1177/09636897211027521

Figure Lengend Snippet: (A) ESR1 expression in OV stage II–IV was higher than stage I and Fig. 1B low survival probability related to high ESR1 level from TCGA ( P = 0.022) (B) Immunohistochemical staining images (up) and scores (down) of KMT2D, ESR1 and H3K4me in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including tumor samples and adjacent tissues.). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (C) The protein expression of KMT2D, ESR1, PTGS2, STAT3, VEGFR2 in tumor tissues of phase I ( n = 38), phase II ( n = 58), phase III ( n = 60) and phase IV ( n = 42) OV patients and adjacent tissues (including 198 tumor samples and 133 adjacent tissues). (phase I vs phase II P < 0.05, phase II vs phase III P < 0.001, phase III vs phase IV N.S. , two-sided unpaired t -test). (D) The binding of H3K4me and ESR1 was demonstrated using CHIP analysis and the relative expression of ESR1 was calculated via normalized to the Input group. Scale bar: 50 μm. * P < 0.05 vs adjacent tissues, ** P < 0.01 vs adjacent tissues, # P < 0.05 vs tumor (phase I), ## P < 0.01 vs tumor (phase I).

Article Snippet: The adenovirus vector for KMT2D interference, the plasmid for point mutation at H3K4 site, as well as the activator and inhibitor of KMT2D were constructed by GenePharma Co., Ltd (Shanghai, China), which were subsequently transfected into SKOV3 and HO-8910 cell lines for 48 h, respectively.

Techniques: Expressing, Immunohistochemical staining, Staining, Binding Assay

(A) Expression of KMT2D, ESR1, H3K4me in IOSE80 and SKOV3 cell lines were determined using immunofluorescence and located by DAPI staining. (B) Expression of KMT2D, ESR1, FOXL2, PTGS2, and VEGFR2 detected by western blotting. The relative expression was calculated via normalization to the expression of actin. Scale bar: 20 μm. * P < 0.05 vs IOSE80, ** P < 0.01 vs IOSE80, # P < 0.05 vs model control group, ## P < 0.01 vs model control group.

Journal: Cell Transplantation

Article Title: Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer

doi: 10.1177/09636897211027521

Figure Lengend Snippet: (A) Expression of KMT2D, ESR1, H3K4me in IOSE80 and SKOV3 cell lines were determined using immunofluorescence and located by DAPI staining. (B) Expression of KMT2D, ESR1, FOXL2, PTGS2, and VEGFR2 detected by western blotting. The relative expression was calculated via normalization to the expression of actin. Scale bar: 20 μm. * P < 0.05 vs IOSE80, ** P < 0.01 vs IOSE80, # P < 0.05 vs model control group, ## P < 0.01 vs model control group.

Article Snippet: The adenovirus vector for KMT2D interference, the plasmid for point mutation at H3K4 site, as well as the activator and inhibitor of KMT2D were constructed by GenePharma Co., Ltd (Shanghai, China), which were subsequently transfected into SKOV3 and HO-8910 cell lines for 48 h, respectively.

Techniques: Expressing, Immunofluorescence, Staining, Western Blot

(A) OV tumor size in mice was measured by ruler (mm 3 ). (B) Relative mRNA expression of ESR1, ELF3, and STAT3 determined using qRT-PCR and calculated via normalization to the mRNA level of GAPDH. (C) Expression of KMT2D, ESR1, H4K3me, PTGS2, and VEGFR2 detected by western blotting. The relative expression was calculated via normalization to the expression of actin. (D) The binding of H3K4me and ESR1 was demonstrated using CHIP analysis and the relative expression of ESR1 was calculated via normalized to the Input group. * P < 0.05 vs IOSE80, ** P < 0.01 vs IOSE80, # P < 0.05 vs model control group, ## P < 0.01 vs model control group.

Journal: Cell Transplantation

Article Title: Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer

doi: 10.1177/09636897211027521

Figure Lengend Snippet: (A) OV tumor size in mice was measured by ruler (mm 3 ). (B) Relative mRNA expression of ESR1, ELF3, and STAT3 determined using qRT-PCR and calculated via normalization to the mRNA level of GAPDH. (C) Expression of KMT2D, ESR1, H4K3me, PTGS2, and VEGFR2 detected by western blotting. The relative expression was calculated via normalization to the expression of actin. (D) The binding of H3K4me and ESR1 was demonstrated using CHIP analysis and the relative expression of ESR1 was calculated via normalized to the Input group. * P < 0.05 vs IOSE80, ** P < 0.01 vs IOSE80, # P < 0.05 vs model control group, ## P < 0.01 vs model control group.

Article Snippet: The adenovirus vector for KMT2D interference, the plasmid for point mutation at H3K4 site, as well as the activator and inhibitor of KMT2D were constructed by GenePharma Co., Ltd (Shanghai, China), which were subsequently transfected into SKOV3 and HO-8910 cell lines for 48 h, respectively.

Techniques: Expressing, Quantitative RT-PCR, Western Blot, Binding Assay

RV-induced dynamic Ca 2+ signaling is related to virus dose. ( A) Immunofluorescence images of mock or SA114F-infected MA104-GCaMP5G cells that were inoculated with increasing MOI (0.1, 1, or 10). RV antigen (red) is detected at ~8 hpi with anti-RV polyclonal antisera and nuclei are stained with DAPI (blue). (B , C) Epifluorescence images of MA104-GCaMP5G cells mock or infected with recombinant SA11-mRuby reporter virus with increasing MOIs (0.1, 1, 10). Images were captured at 7 HPI (B) or 10 HPI (C) . (D) Representative single-cell traces of relative GCaMP5G fluorescence (F/F 0 ) from cells mock (black) or RV infected by SA114F with MOIs of 0.1 (purple), 1 (blue), 10 (red). (E) Representative single-cell traces of relative fluorescence (F/F 0 ) of GCaMP5G (green) and mRuby (red) from cells infected by SA11-mRuby MOI 0.1 (purple) or 1 (blue). (F , G) Number of Ca 2+ spikes (F/F 0 > 5%) from mock or RV-infected cells that were infected with SA114F (F) or SA11-mRuby (G) . Data shown as mean ± SD of 60 cells/condition. **p < 0.01.

Journal: Scientific Reports

Article Title: Rotavirus Calcium Dysregulation Manifests as Dynamic Calcium Signaling in the Cytoplasm and Endoplasmic Reticulum

doi: 10.1038/s41598-019-46856-8

Figure Lengend Snippet: RV-induced dynamic Ca 2+ signaling is related to virus dose. ( A) Immunofluorescence images of mock or SA114F-infected MA104-GCaMP5G cells that were inoculated with increasing MOI (0.1, 1, or 10). RV antigen (red) is detected at ~8 hpi with anti-RV polyclonal antisera and nuclei are stained with DAPI (blue). (B , C) Epifluorescence images of MA104-GCaMP5G cells mock or infected with recombinant SA11-mRuby reporter virus with increasing MOIs (0.1, 1, 10). Images were captured at 7 HPI (B) or 10 HPI (C) . (D) Representative single-cell traces of relative GCaMP5G fluorescence (F/F 0 ) from cells mock (black) or RV infected by SA114F with MOIs of 0.1 (purple), 1 (blue), 10 (red). (E) Representative single-cell traces of relative fluorescence (F/F 0 ) of GCaMP5G (green) and mRuby (red) from cells infected by SA11-mRuby MOI 0.1 (purple) or 1 (blue). (F , G) Number of Ca 2+ spikes (F/F 0 > 5%) from mock or RV-infected cells that were infected with SA114F (F) or SA11-mRuby (G) . Data shown as mean ± SD of 60 cells/condition. **p < 0.01.

Article Snippet: Lentivirus constructs encoding shRNA targeting SA11 gene 10 and a non-targeting scrambled shRNA negative control were generated and packaged by America Pharma Source, LLC.

Techniques: Virus, Immunofluorescence, Infection, Staining, Recombinant, Fluorescence